GlassScriptPhysician profile
Daniel Paul Carpenter
NPI 1831502558
$2,825.97
in general payments reported to CMS, 2019-2025
12 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,506 · 2020: $141 · 2021: $188 · 2022: $242 · 2023: $407 · 2024: $241 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $749.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $1,372.01 | 2019-2020 | |
| Stryker Corporation | $681.79 | 2021-2025 | Aequalis Flex Revive, Aequalis Ascend Flex, Aequalis Perform Reversed |
| Tricoast Surgical Solutions LLC | $155.29 | 2023 | |
| Alphatec Spine, INC | $143.26 | 2019 | |
| Endo Pharmaceuticals INC. | $112.40 | 2022-2024 | Xiaflex |
| Endo USA, INC. | $77.87 | 2024-2025 | Xiaflex |
| Depuy Synthes Sales INC. | $76.96 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $54.24 | 2019-2020 | |
| Bioventus LLC | $51.90 | 2022-2024 | Exogen Ultrasound Bone Healing System |
| Ermi LLC | $50.61 | 2022 | |
| Ferring Pharmaceuticals INC. | $26.50 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $23.14 | 2023 | Dysport |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Carpenter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.